236 related articles for article (PubMed ID: 24067604)
1. Prevalence and factors related to hepatitis B and C infection in inflammatory bowel disease patients in China: a retrospective study.
Huang ML; Xu XT; Shen J; Qiao YQ; Dai ZH; Ran ZH
J Crohns Colitis; 2014 Apr; 8(4):282-7. PubMed ID: 24067604
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and factors related to hepatitis B and C in inflammatory bowel disease patients in Spain: a nationwide, multicenter study.
Loras C; Saro C; Gonzalez-Huix F; Mínguez M; Merino O; Gisbert JP; Barrio J; Bernal A; Gutiérrez A; Piqueras M; Calvet X; Andreu M; Abad A; Ginard D; Bujanda L; Panés J; Torres M; Fernández-Bañares F; Viver JM; Esteve M;
Am J Gastroenterol; 2009 Jan; 104(1):57-63. PubMed ID: 19098850
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis B and C and factors for infection and nonimmune in inflammatory bowel disease patients in China.
Chen D; Luo S; Ben Q; Lu L; Wan X; Wu J
Eur J Gastroenterol Hepatol; 2017 May; 29(5):509-515. PubMed ID: 28350740
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory bowel disease and hepatitis B and C in Western Balkans: a referral centre study and review of the literature.
Katsanos KH; Tsianos VE; Zois CD; Zioga H; Vagias I; Zervou E; Christodoulou DK; Tsianos EV;
J Crohns Colitis; 2010 Oct; 4(4):450-65. PubMed ID: 21122543
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of hepatitis-B viral markers in patients with inflammatory bowel disease in a hepatitis-B-endemic area: inadequate protective antibody levels in young patients.
Kim ES; Cho KB; Park KS; Jang BI; Kim KO; Jeon SW; Kim EY; Yang CH; Kim WJ;
J Clin Gastroenterol; 2014 Jul; 48(6):553-8. PubMed ID: 24162170
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis B and C virus infection in Crohn's disease.
Biancone L; Pavia M; Del Vecchio Blanco G; D'Incà R; Castiglione F; De Nigris F; Doldo P; Cosco F; Vavassori P; Bresci GP; Arrigoni A; Cadau G; Monteleone I; Rispo A; Fries W; Mallardi B; Sturniolo GC; Pallone F;
Inflamm Bowel Dis; 2001 Nov; 7(4):287-94. PubMed ID: 11720317
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and natural history of hepatitis B and C infections in a large population of IBD patients treated with anti-tumor necrosis factor-α agents.
Papa A; Felice C; Marzo M; Andrisani G; Armuzzi A; Covino M; Mocci G; Pugliese D; De Vitis I; Gasbarrini A; Rapaccini GL; Guidi L
J Crohns Colitis; 2013 Mar; 7(2):113-9. PubMed ID: 22464811
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of hepatitis B and C and risk factors for nonvaccination in inflammatory bowel disease patients in Northeast France.
Chevaux JB; Nani A; Oussalah A; Venard V; Bensenane M; Belle A; Gueant JL; Bigard MA; Bronowicki JP; Peyrin-Biroulet L
Inflamm Bowel Dis; 2010 Jun; 16(6):916-24. PubMed ID: 19885908
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B vaccination in patients with inflammatory bowel disease.
Ben Musa R; Gampa A; Basu S; Keshavarzian A; Swanson G; Brown M; Abraham R; Bruninga K; Losurdo J; DeMeo M; Mobarhan S; Shapiro D; Mutlu E
World J Gastroenterol; 2014 Nov; 20(41):15358-66. PubMed ID: 25386085
[TBL] [Abstract][Full Text] [Related]
10. Factors for hepatitis B vaccination and abnormal liver function in Chinese patients with inflammatory bowel disease: a single center experience.
Leung WK; Liu KSh; Seto WK; Chan KH; Tong T; Yuen MF; Lai CL; Hung IF
J Dig Dis; 2013 Nov; 14(11):596-603. PubMed ID: 23870196
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
13. Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection.
Morisco F; Castiglione F; Rispo A; Stroffolini T; Sansone S; Vitale R; Guarino M; Biancone L; Caruso A; D'Inca R; Marmo R; Orlando A; Riegler G; Donnarumma L; Camera S; Zorzi F; Renna S; Bove V; Tontini G; Vecchi M; Caporaso N
J Viral Hepat; 2013 Mar; 20(3):200-8. PubMed ID: 23383659
[TBL] [Abstract][Full Text] [Related]
14. Review article: prevention and management of hepatitis B and C infection in patients with inflammatory bowel disease.
Gisbert JP; Chaparro M; Esteve M
Aliment Pharmacol Ther; 2011 Mar; 33(6):619-33. PubMed ID: 21416659
[TBL] [Abstract][Full Text] [Related]
15. Inadequate seroprotection against hepatitis B virus and one detected case of hepatitis C virus infection among patients with inflammatory bowel disease.
Waszczuk E; Waszczuk KM; Mulak A; Paradowski L
Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):628-32. PubMed ID: 26904976
[TBL] [Abstract][Full Text] [Related]
16. Clinical courses of chronic hepatitis B virus infection and inflammatory bowel disease in patients with both diseases.
Park SH; Yang SK; Lim YS; Shim JH; Yang DH; Jung KW; Kim KJ; Ye BD; Byeon JS; Myung SJ; Kim JH
Inflamm Bowel Dis; 2012 Nov; 18(11):2004-10. PubMed ID: 22337144
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and characterization of hepatitis B and C virus infections in a needle-sharing population in Northern China.
Xu CJ; Zhang CP; Luo BF; Liu LJ; Wang YZ; Wang XH; He QJ; Zhou SS; Guo WS; Wang JH; Yang RF; Zhang HY; Rao HY; Feng B; Wei L
BMC Public Health; 2015 May; 15():460. PubMed ID: 25933922
[TBL] [Abstract][Full Text] [Related]
18. HBV and HCV infection in Japanese dental care workers.
Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M
Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B and C viral infections screening in a Tunisian IBD population under immunosuppressive therapies.
Sabbah M; Yacoub H; Bellil N; Trad D; Ouakaa A; Elloumi H; Bbani N; Gargouri D
Rev Gastroenterol Peru; 2020; 40(3):246-251. PubMed ID: 33181811
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab.
Moses J; Alkhouri N; Shannon A; Raig K; Lopez R; Danziger-Isakov L; Feldstein AE; Zein NN; Wyllie R; Carter-Kent C
Am J Gastroenterol; 2012 Jan; 107(1):133-8. PubMed ID: 21876562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
